Birt, L.
Dalgarno, L.
Bond, C. M.
Holland, R.
Alldred, D. P.
Hughes, C.
Blyth, A.
Watts, L.
Wright, D. J.
,
Funding for this research was provided by:
National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme (RP-PG-0613-20007, RP-PG-0613-20007, RP-PG-0613-20007, RP-PG-0613-20007, RP-PG-0613-20007, RP-PG-0613-20007, RP-PG-0613-20007, RP-PG-0613-20007, RP-PG-0613-20007)
Article History
Received: 27 October 2021
Accepted: 16 June 2022
First Online: 15 July 2022
Declarations
:
: English ethical approval was gained from East of England Cambridge Central Research Ethics Committee 17/EE/0360 (28.11.2017; this applied to research in Northern Ireland. Scottish ethical approval was gained from Scotland A research Ethics Committee 17/SS/0118 (07.12.2017). Written informed consent was obtained from all subjects. No subjects were under 16 years of age. All methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: DW received speaker fees from Desitin Pharma and speaker fees and unrestricted education grants from Rosemont Pharmaceuticals. All other authors have no competing/conflict of interest.